D药业集团的满药生产现状及对策研究
发布时间：2019-04-27 19:48
【摘要】：目的:本课题将对D药业集团满药生产的现状进行调查研究,找出D药业集团满药生产中存在的问题,进一步提出加快D药业集团满药发展有效的建议和对策,推动满药产业的发展,进而提高民众健康素养,有效促进民生幸福。方法:本论文首先概述了相关理论及法律法规;其次,运用文献研究法查阅有关满药的书籍、期刊、报纸和互联网上的资料,作为研究D药业集团满药生产现状的基础。通过相关人士访谈法,并采用理论知识与实际调查相结合的方法,来反映D药业集团满药生产的发展现状。最后,分析调研结果。结果:调查结果显示在近年民族药产业发展迅猛的大环境下,满药产业也在迅速的发展。辽宁省有丰富的满药材资源。满药是一种独具特色的民族药。但至今满药尚未形成完整的体系,D药业集团满药生产现状仍存在研发、生产和营销方面的问题。结论:为了推动满药产业的健康发展,介于对书籍、期刊、报纸和互联网上资料的研读以及相关人士访谈的调研,提出以下几点有针对性的对策与建议:D药业集团在研发方面要以市场为导向,联合产、学、研并二次研发大品种。D药业集团在生产方面要规范化生产,对生产技术进行创新并实行全面质量管理。D药业集团在营销方面要提高顾客满意度并打造满药品牌。本研究的创新之处在于:目前对满药产业领域的研究很少,本论文也是满药企业生产现状研究的第一例。本文采用文献研究法和相关人士访谈法,对D药业集团满药生产的现状做以调查,在发现D药业集团满药生产中存在的问题之后,对其存在的问题加以解决。
[Abstract]:Objective: this subject will investigate and study the current situation of drug production in D pharmaceutical group, find out the problems existing in the drug production in D pharmaceutical group, and put forward some effective suggestions and countermeasures to speed up the development of Manchu medicine in D pharmaceutical group, and to find out the problems existing in the drug production in D pharmaceutical group. Promote the development of Manchu medicine industry, and further improve people's health literacy, effectively promote people's well-being. Methods: firstly, the related theories, laws and regulations were summarized, secondly, books, periodicals, newspapers and Internet about Manchurian drugs were reviewed by literature research method, which was the basis of studying the present situation of Manchurian medicine production in D Pharmaceutical Group. Through the method of interview with relevant people and the combination of theoretical knowledge and practical investigation, this paper reflects the present situation of the development of Manchu drug production in D Pharmaceutical Group. Finally, the research results are analyzed. Results: the investigation results showed that under the environment of the rapid development of the national drug industry in recent years, the full drug industry was also developing rapidly. Liaoning Province has abundant resources of Manchu medicinal materials. Manchu is a unique national medicine. However, there are still some problems in R & D, production and marketing in D Pharmaceutical Group. Conclusion: in order to promote the healthy development of the Manchurian medicine industry, the study of books, periodicals, newspapers and the Internet, as well as interviews with relevant people, The following targeted countermeasures and suggestions are put forward: in R & D, D Pharmaceutical Group should be market-oriented, co-produce, study, research and research twice on large varieties. D Pharmaceutical Group should standardize production in terms of production. Innovation in production technology and implementation of total quality management. D Pharmaceutical Group in the marketing aspect to improve customer satisfaction and build a full brand of drugs. The innovation of this study is that there is little research on Manchu medicine industry at present, and this paper is also the first example of the study on the production status of Manchu medicine enterprises. In this paper, by means of literature research and interviews with relevant people, the present situation of drug production in D pharmaceutical group is investigated. After discovering the problems existing in the drug production in D pharmaceutical group, the existing problems are solved.
【学位授予单位】：辽宁中医药大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：F426.72
本文编号：2467262
[Abstract]:Objective: this subject will investigate and study the current situation of drug production in D pharmaceutical group, find out the problems existing in the drug production in D pharmaceutical group, and put forward some effective suggestions and countermeasures to speed up the development of Manchu medicine in D pharmaceutical group, and to find out the problems existing in the drug production in D pharmaceutical group. Promote the development of Manchu medicine industry, and further improve people's health literacy, effectively promote people's well-being. Methods: firstly, the related theories, laws and regulations were summarized, secondly, books, periodicals, newspapers and Internet about Manchurian drugs were reviewed by literature research method, which was the basis of studying the present situation of Manchurian medicine production in D Pharmaceutical Group. Through the method of interview with relevant people and the combination of theoretical knowledge and practical investigation, this paper reflects the present situation of the development of Manchu drug production in D Pharmaceutical Group. Finally, the research results are analyzed. Results: the investigation results showed that under the environment of the rapid development of the national drug industry in recent years, the full drug industry was also developing rapidly. Liaoning Province has abundant resources of Manchu medicinal materials. Manchu is a unique national medicine. However, there are still some problems in R & D, production and marketing in D Pharmaceutical Group. Conclusion: in order to promote the healthy development of the Manchurian medicine industry, the study of books, periodicals, newspapers and the Internet, as well as interviews with relevant people, The following targeted countermeasures and suggestions are put forward: in R & D, D Pharmaceutical Group should be market-oriented, co-produce, study, research and research twice on large varieties. D Pharmaceutical Group should standardize production in terms of production. Innovation in production technology and implementation of total quality management. D Pharmaceutical Group in the marketing aspect to improve customer satisfaction and build a full brand of drugs. The innovation of this study is that there is little research on Manchu medicine industry at present, and this paper is also the first example of the study on the production status of Manchu medicine enterprises. In this paper, by means of literature research and interviews with relevant people, the present situation of drug production in D pharmaceutical group is investigated. After discovering the problems existing in the drug production in D pharmaceutical group, the existing problems are solved.
【学位授予单位】：辽宁中医药大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：F426.72
【参考文献】
相关期刊论文 前6条
1 李赫;;首届中国满族医药及健康产品博览会暨2016第四届满族医药国际论坛在辽宁丹东举行[J];满族研究;2016年03期
2 刘志学;;宋玉荣:钟情“满族医药”三十年[J];中国医药导报;2012年19期
3 詹洪春;;民族医药再推“满族医药”新品牌[J];中国当代医药;2010年24期
4 马万学;刘玉忠;;满族传统医药的传承与应用[J];满族研究;2009年02期
5 ;数据表明:我国民族药材品种已达8000多种[J];中药研究与信息;2005年12期
6 梁廷信;满族常用药简介[J];中国民族医药杂志;2000年01期
相关会议论文 前1条
1 林瑞超;;中国民族药的现状与发展[A];2013年中国药学大会暨第十三届中国药师周报告集[C];2013年
相关重要报纸文章 前6条
1 张旭;;丹东：打造中国“满药”之都[N];中国中医药报;2014年
2 罗朝淑;;辽宁丹东着力打造中国“满药之都”[N];科技日报;2014年
3 王抒婧;;白山黑水间的满族医药文化[N];丹东日报;2013年
4 李瑶;;后起民族药期待理论上位[N];医药经济报;2012年
5 陶晋;;2012满族医药国际论坛在丹举行[N];丹东日报;2012年
6 丛晓明;;振兴满族医药[N];丹东日报;2012年
相关博士学位论文 前1条
1 范春芳;少数民族药产业科学发展的路径研究[D];中央民族大学;2010年
相关硕士学位论文 前2条
1 赵琪;内蒙古大唐药业有限公司中蒙药战略研究[D];内蒙古大学;2013年
2 方曦;贵州省中小制药企业发展战略研究[D];上海交通大学;2009年
，本文编号：2467262
本文链接：https://www.wllwen.com/gongshangguanlilunwen/2467262.html
